Issuance and allotment of Equity Shares and Warrants by way of Preferential Issue ('Preferential Issue'). Please refer to the enclosed file.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.3 pts more than Nifty Microcap 250 and 8.2 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Shree Pacetronix Ltd, at its meeting on August 7, 2025, approved multiple items including the Unaudited Financial Results (standalone and consolidated) for Q1 FY26 (quarter ended June 30, 2025), which received an unmodified (clean) opinion from the auditors. The Board also approved a Preferential Issue to promoter Mr. Akash Sethi (Joint Managing Director) to raise up to Rs. 2.43 crore through 75,150 equity shares at Rs. 81 each and up to 2,25,450 convertible warrants at the same price, in two series exercisable over 9 and 18 months respectively. Post-issue, Mr. Akash Sethi's stake will rise from 0.35% to about 8.03% of the company, triggering a mandatory open offer under SEBI takeover rules. Additionally, Mr. Atul Kumar Sethi (father of the allottee) was reappointed as Managing Director for three years from December 1, 2025 to November 30, 2028. The 37th AGM has been scheduled for September 3, 2025.
Existing shareholders may see modest dilution (about 7.7%) from the promoter-led preferential issue, though the small size (Rs. 2.43 crores) limits the impact. The mandatory open offer following the allotment could give existing shareholders an exit opportunity, while promoter strengthening signals confidence in the business.